JH

Jack Hoppin

CEO

Ratio Therapeutics

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Ratio Therapeutics
Industry
research
Employees
56.0
Seniority
C suite
Annual Revenue
1500000.0
Total Funding
90000000.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 Google Tag Manager Wordpress.com Nginx Mobile Friendly WordPress.org Render Remote AI

Keywords

biotechnology research radiopharmaceuticals cancer treatment theranostics targeted therapy sstr2-targeting alpha-emitting radionuclides companion diagnostics pharmacokinetics modulation clinical trials fap-targeted therapy tumor delivery tumor-killing preclinical development drug development innovative technologies imaging & therapeutic antibody drug conjugates oncology fibroblast activation protein novel drug candidates partnerships with pharma clinical studies biotechnology drug discovery cancer differentiation radioligand therapy pipeline development biopharmaceuticals regulatory science licensing agreements collaboration with novartis tunable compounds proprietary technology biotech innovation small molecule targeting agents chemical compatibility drug availability in vivo stability multimodal approaches tumor penetration radionuclide therapy patient-centric treatment advanced cancer therapies personalized medicine disease-specific diagnostics market position research & development target identification clinical operations academic collaboration health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans